Alnylam Pharmaceuticals
ALNY
#672
Rank
ยฃ28.16 B
Marketcap
ยฃ210.97
Share price
-2.26%
Change (1 day)
-7.14%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company